Please use this identifier to cite or link to this item: http://hdl.handle.net/10419/50386
Authors: 
Akkoyunlu, Sule
Lichtenberg, Frank R.
Siliverstovs, Boriss
Zweifel, Peter
Year of Publication: 
2009
Series/Report no.: 
KOF working papers // KOF Swiss Economic Institute, ETH Zurich 227
Abstract: 
In this paper, we address the issue of spurious correlation in the production of health in a systematic way. Spurious correlation entails the risk of linking health status to medical (and nonmedical) inputs when no links exist. This note first presents the bounds testing procedure as a method to detect and avoid spurious correlation. It then applies it to a recent contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health care expenditure. The results of the bounds testing procedure show longevity to be linearly related to these two factors. Therefore, the estimates reported by Lichtenberg (2004) cannot be said to be result of spurious correlation, to the contrary, they very likely reflect an effective relationship, at least for the United States.
Subjects: 
Health
Life expectancy
Innovation
Pharmaceuticals
Health care expenditure
Cointegration
JEL: 
H51
I12
J18
C22
O33
Persistent Identifier of the first edition: 
Document Type: 
Working Paper

Files in This Item:
File
Size
156.91 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.